Genetic manipulation of insulin signaling, action and secretion in mice. Insights into glucose homeostasis and pathogenesis of type 2 diabetes

EMBO Reports

Volumn 3, Issue 4, 2002, Pages 323-328

  Baudry, Anna ^a   Leroux, Loïc ^a   Jackerott, Malene ^a   Joshi, Rajiv L ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DIABETOGENESIS; GENE EXPRESSION; GENETIC ENGINEERING; GENETIC MANIPULATION; GLUCOSE HOMEOSTASIS; INSULIN RELEASE; INSULIN RESISTANCE; KNOCKOUT MOUSE; MOUSE; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS DISEASE; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; INSULIN; ISLETS OF LANGERHANS; MICE; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; PHOSPHOPROTEINS; POTASSIUM CHANNELS; SIGNAL TRANSDUCTION;

ANIMALIA; MUS MUSCULUS;

EID: 0036250193     PISSN: 1469221X     EISSN: None     Source Type: Journal    
DOI: 10.1093/embo-reports/kvf078     Document Type: Review

References (39)

1. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
2. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene
3. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
4. Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene
5. Development of novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles
6. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
7. Role of brain insulin receptor in control of body weight and reproduction
8. Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetes genes
9. The diabetogenes concept of NIDDM
10. Phenotypic alterations in insulin-deficient mutant mice
11. Transgenic knockouts reveal a critical requirement for pancreatic β cell glucokinase in maintaining glucose homeostasis
12. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2
13. Endocrine pancreas in insulin receptor-deficient mouse pups
14. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality
15. Type 2 diabetes: When insulin secretion fails to compensate for insulin resistance
16. Insulin action, diabetogenes, and the cause of type II diabetes
17. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4
18. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1 and IRS-2
19. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle
20. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory β-cell hyperplasia
21. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes
22. Compensatory responses in mice carrying a null mutation for Ins1 or Ins2
23. Hyperinsulinemia in transgenic mice carrying multiple copies of the human insulin gene
24. A model to explore the interaction between muscle insulin resistance and β-cell dysfunction in the development of type 2 diabetes
25. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction
26. ATP channel-deficient mice
27. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic β cell-specific gene knock-outs using Cre recombinase
28. ATP channel-independent regulation of insulin secretion
29. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes
30. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
31. Pancreatic β-cell specific targeted disruption of glucokinase gene
32. Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and β cell glucokinase genes
33. Transgenic reexpression of GLUT1 or GLUT2 in pancreatic β-cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion
34. Muscle-specific transgenic complementation of GLUT-4-deficient mice
35. Signal transduction by receptors with tyrosine kinase activity
36. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus
37. The insulin signaling system
38. Disruption of IRS-2 causes type 2 diabetes in mice
39. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance